ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2022 American Transplant Congress

    A Real-World Analysis with the Molecular Microscope Diagnostic System in Dual-Organ Transplant Recipients

    J. M. Blair1, J. Van Zyl2, G. P. Milligan3, S. M. McKean2, R. Patel2, S. A. Hall4, A. Alam3

    1Cardiology, Baylor University Medical Center at Dallas, Dallas, TX, 2Baylor University Medical Center at Dallas, Dallas, TX, 3Advanced Heart Failure & Transplant Cardiology, Baylor University Medical Center at Dallas, Dallas, TX, 4Transplant Cardiology and Mechanical Support/Heart Failure, Baylor University Medical Center at Dallas, Dallas, TX

    *Purpose: The Molecular Microscope Diagnostic System (MMDx) analyzes ribonucleic acid transcripts to provide sophisticated differentiation amongst T-cell mediated rejection (TCMR), antibody mediated rejection (AMR), injury…
  • 2022 American Transplant Congress

    Of the Individual Components of a Modified Freid Frailty Score, Pre-Transplant Walk Time and Grip Strength Are the Strongest Predictors of Post Kidney Transplant Outcomes

    S. Parajuli, F. Aziz, H. L. Lorden, K. A. O'Toole, R. E. Wallschlaeger, I. C. Breyer, B. Dodin, J. Goronzik Wang, D. A. Mandelbrot

    University of Wisconsin, Madison, WI

    *Purpose: Frailty assessment has become common during evaluation for kidney transplantation; however, a variety of different tools are used for frailty assessment. The Freid frailty…
  • 2022 American Transplant Congress

    Gm2a: A Novel Regulatory Pathway Controlling CD8+ T Cell Alloimmunity

    K. M. Baecher1, J. Bazzano1, K. Tong1, M. Fribourg2, P. Cravedi2, P. S. Heeger2, M. L. Ford1

    1Department of Surgery, Emory University, Atlanta, GA, 2Mount Sinai School of Medicine, New York, NY

    *Purpose: Transplant recipients experience lifelong immunosuppression, yet studies have shown that a subset of patients may be able to retain stable graft function even with…
  • 2022 American Transplant Congress

    Standard Induction with Basiliximab versus no Induction in Low Immunological Risk Kidney Transplant Recipients: Study Protocol for a Randomized Controlled Trial

    A. Ajlan1, H. Aleid1, T. Ali1, H. Joharji1, Z. Alabdulkarim1, T. Aburiash1, K. Almeshari1, A. Nazmi1, Y. Shah1, E. Devol1, D. Alkortas1, D. Broering1, I. Alahmadi1, A. Ullah1, A. Alotaibi1, A. Aljedai2

    1KFSHRC, RIYADH, Saudi Arabia, 2MOH, RIYADH, Saudi Arabia

    *Purpose: To compare different induction therapeutic strategies with 2 doses of basiliximab vs. no induction in low immunologic risk kidney transplant recipients as per KFSHRC…
  • 2022 American Transplant Congress

    Urinary Exosomal MicroRNA Biomarkers for Antibody-Mediated Rejection After Kidney Transplantation

    S. Shin, M. Kim, S. Lim, H. Kwon, J. Jung, Y. Ko, H. Kwon, Y. Kim

    Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of

    *Purpose: We aimed to identify urine-derived exosomal miRNAs as diagnostic biomarkers for antibody-mediated rejection (ABMR) after kidney transplantation.*Methods: Exosomal miRNAs using differential ultracentrifugation were isolated…
  • 2022 American Transplant Congress

    Use of Three-Dimensional Volumetric Analysis to Monitor Acute Rejection in a Face Transplant Recipient

    D. Boczar1, H. Brydges1, O. C. Onuh1, B. F. Chaya1, J. Trilles1, R. Rodriguez Colon1, D. J. Ceradini1, B. E. Gelb2, E. D. Rodriguez1

    1Hansjörg Wyss Department of Plastic Surgery, NYU Langone Health, New York, NY, 2Transplant Institute, NYU Langone Health, New York, NY

    *Purpose: The purpose of this study is to determine the feasibility of using 3D facial stereography to monitor volume changes in a facial allograft, and…
  • 2022 American Transplant Congress

    B and Plasma Cell Populations Drive Chronic Rejection After Lung Transplantation

    M. Bueno1, N. F. Smirnova2, K. Riemondy3, P. Suresh1, M. Brown1, X. Wang1, S. Collins4, J. Sembrat1, M. Koenigshoff1, M. Snyder1, J. McDyer1, O. Eickelberg1

    1Pulmonary and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, 2I2MC, INSERM UMR1297, Toulouse, France, 3Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, 4Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO

    *Purpose: Chronic lung allograft dysfunction (CLAD) remains the major determinant of morbidity and mortality post-lung transplantation (LTx). Bronchiolitis obliterans syndrome (BOS) is the most prevalent…
  • 2022 American Transplant Congress

    Delta Changes in Donor-Derived Cell-Free DNA (dd-cfDNA) Complement the Donor Fraction in Kidney Transplant Surveillance

    A. Wiseman1, M. Jagadeesan2, G. Gupta3, V. Rao4, M. Narayanan5, N. Agrawal6, G. Shekhtman6, Y. Fu6, K. Pinney6, S. Anand7

    1Centura Health, Denver, CO, 2George Washington University, Washington, DC, 3Virginia Commonwealth University, Richmond, VA, 4Medical University of South Carolina, Charleston, SC, 5Baylor Scott and White, Austin, TX, 6CareDx, Brisbane, CA, 7Intermountain Healthcare, Murray, UT

    *Purpose: Delta changes in dd-cfDNA levels over time may identify patients with evolving alloimmune injury, providing complementary information to the donor fraction. We explored the…
  • 2022 American Transplant Congress

    Use of De Novo mTOR Inhibitors in Highly Sensitized Kidney Transplant Recipients

    J. Bastos1, T. Freesz2, C. Bisi3, C. Marinho2, A. Pires2, V. Colares3, R. Neto2, G. Ferreira2

    1Tranplant Unit, Santa Casa De Misericordia De Juiz de Fora, Juiz de Fora, Brazil, 2Transplant Unit, Santa Casa De Misericórdia De Juiz de Fora, Juiz de Fora, Brazil, 3Tranplant Unit, Santa Casa De Misericórdia De Juiz de Fora, Juiz de Fora, Brazil

    *Purpose: mTOR inhibitors (mTORi) allow calcineurin-inhibitor reduction without loss of efficacy and may improve allograft-transplant outcomes. However, the safety of this protocol in high-immunological risk…
  • 2022 American Transplant Congress

    Re-Examining the Optimal Threshold for Donor Derived Cell Free DNA in Renal Allograft Rejection

    H. Murad1, M. Merzkani1, M. Ji1, S. Chang1, A. Malone1, R. Delos Santos1, T. Alhamad2

    1Washington University in St. Louis, St Louis, MO, 2Washington University in St. Louis, Saint Louis, MO

    *Purpose: Due to the invasive nature and potential complications of allograft biopsies, there is an important role for surrogate biomarkers to help identify rejection early,…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences